# Mesoblast Limited (MEOBF)

> 医疗保健 · AU · 以 USD 报告

Sponda 的基本面指标，已按通胀调整。

[HTML 版本](https://sponda.capital/zh/MEOBF/fundamentals)

## 年度数据

| 年份 | 营业收入 (M) | 净利润 (M) | FCF (M) | 债务 (M) | 股东权益 (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 51.34M | $ -40.16M | $ -35.41M | $ 135.14M | $ 574.68M |
| 2025 | $ 17.61M | $ -104.58M | $ -52.09M | $ 128.16M | $ 597.44M |
| 2024 | $ 6.20M | $ -92.45M | $ -29.28M | $ 118.92M | $ 480.36M |
| 2023 | $ 8.11M | $ -88.54M | $ -68.75M | $ 116.50M | $ 501.84M |
| 2022 | $ 11.41M | $ -102.04M | $ -73.74M | $ 106.91M | $ 497.04M |
| 2021 | $ 8.84M | $ -117.45M | $ -56.71M | $ 105.50M | $ 581.40M |
| 2020 | $ 40.27M | $ -99.29M | $ -74.67M | $ 99.31M | $ 549.33M |
| 2019 | $ 21.59M | $ -115.91M | $ -74.95M | $ 81.29M | $ 481.05M |
| 2018 | $ 22.65M | $ -46.61M | $ -99.33M | $ 59.40M | $ 546.01M |
| 2017 | $ 3.25M | $ -103.48M | $ -129.04M | $ 0 | $ 516.77M |
| 2016 | $ 58.54M | $ -5.68M | $ -122.34M | $ 0 | $ 528.16M |
| 2015 | $ 33.34M | $ -167.60M | $ -166.29M | $ 0 | $ 609.36M |
| 2014 | $ 32.64M | $ -105.67M | $ -106.76M | $ 0 | $ 571.72M |
| 2013 | $ 49.54M | $ -88.15M | $ -79.14M | $ 0 | $ 630.27M |
| 2012 | N/A | N/A | N/A | $ 0 | $ 478.85M |

此视图中不可用的列：annualPriceMultiples, dividends。它们需要实时市场数据，仅在 HTML 页面上显示。

## 杠杆与流动性

| 指标 | 数值 |
| --- | --- |
| 总债务 / 股东权益 | 0.24 |
| 总负债 / 股东权益 | 0.36 |
| 流动比率 | 1.58 |

## 其他视图

- [指标](https://sponda.capital/zh/MEOBF.md)
- [图表](https://sponda.capital/zh/MEOBF/charts.md)
- [对比](https://sponda.capital/zh/MEOBF/compare.md)
- [指标定义](https://sponda.capital/zh/screener.md)

数据截至 2026-08-29。